 BERWYN, Pa.--BUSINESS WIRE-- pharma--Virpax Pharmaceuticals, Inc. Virpax or the Company NASDAQ:VRPX, a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide and seven research and development facilities throughout the U.S. and Europe. The agreement 